Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|June 3, 2021

Syneos Health Launches Patient Voice Consortium

Syneos Health has launched its Patient Voice Consortium. The Consortium is a cross-functional hub designed to share knowledge, resources, and relationships. These efforts seek to define best practices for gaining patient insights to pressure-test, problem-solve and co-create clinical trial design, communications, stakeholder education, access initiatives and launch strategies.

The Consortium builds on Syneos Health knowledge including patient journey mapping, behavioral science referenced in the Syneos Health subject matter authored book Why We Resist and ongoing DE&I efforts designed to expand access and diversity in clinical trials. The Consortium seeks to learn from the widest range of patient communities possible. Inclusive, transparent methodologies, rooted in shared purpose and bidirectional communications, will guide Consortium efforts.

For more information, click here.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.